The increasing role of medical therapy in the management of pituitary tumours

InPharma ◽  
1987 ◽  
Vol 596 (1) ◽  
pp. 2-2
2016 ◽  
Author(s):  
Sayka Barry ◽  
Eivind Carlsen ◽  
Emanuela Gadaleta ◽  
Dan Berney ◽  
Claude Chelala ◽  
...  

2021 ◽  
pp. 1-4
Author(s):  
Charlie J. Sang ◽  
Stephen A. Clarkson ◽  
Elizabeth A. Jackson ◽  
Firas Al Solaiman ◽  
Marc G. Cribbs

Abstract Anomalous coronary arteries from the pulmonary artery are uncommon causes of heart failure in the adult population. This case demonstrates the unusual presentation in a patient with anomalous right coronary artery from the pulmonary artery and discusses the complex pathophysiology of this lesion and the role of guideline-directed medical therapy in the management of these patients.


2021 ◽  
Vol Volume 15 ◽  
pp. 2683-2692
Author(s):  
Mayuresh Naik ◽  
Monika Kapur ◽  
VishnuSwarup Gupta ◽  
HarinderSingh Sethi ◽  
Kartikeya Srivastava

2019 ◽  
Vol 12 (2) ◽  
pp. e226929
Author(s):  
Taha Anwar ◽  
Elizabeth Malm-Buatsi

Infantile haemangiomas are one of the most common tumours in infancy, but typically present as cutaneous lesions; haemangiomas of the urinary bladder are incredibly rare. Although benign, these can sometimes ulcerate and bleed, causing haematuria in the case of bladder lesions. Propranolol is a well-documented medical therapy for cutaneous lesions, but surgical treatment dominates the literature on bladder haemangiomas. We present the case of a child with infantile haemangiomas of the urinary bladder, as well as internal and cutaneous lesions, treated with propranolol. At 6-week follow-up cystoscopy and MRI, there was a significant improvement in both bladder and internal lesions, respectively. Follow-up with dermatology 9 months after initiation of propranolol demonstrated excellent regression of the cutaneous lesions with a marked decrease in both size and prominence. This case demonstrates the potential role of propranolol in the treatment of bladder haemangiomas in lieu of more invasive surgical techniques.


2017 ◽  
Vol 108 (6) ◽  
pp. 913-930 ◽  
Author(s):  
Paolo Vercellini ◽  
Laura Buggio ◽  
Edgardo Somigliana

2004 ◽  
Vol 19 (1) ◽  
pp. 4-6
Author(s):  
D Boudouroglou ◽  
S K Kakkos ◽  
G Geroulakos

No randomized controlled clinical trials have investigated the role of postoperative adjuvant medical therapy in improving the results of deep venous reconstruction. Deep venous thrombosis (DVT) is an important complication following deep valve reconstruction. It may occur at the site of the repaired valve or alternatively in remote sites. There is evidence from randomized controlled trials in many surgical specialties indicating that the combination of anticoagulation and a mechanical method of prophylaxis has an important role in the reduction of postoperative DVT. This combination should be used in the postoperative management of deep venous reconstruction. Additional benefits of the mechanical methods of thromboprophylaxis are a reduction of the postoperative swelling and improved venous haemodynamics.


Sign in / Sign up

Export Citation Format

Share Document